YX

Yurong Xin

RP Regeneron Pharmaceuticals: 9 patents #133 of 810Top 20%
📍 Ashland, MA: #54 of 345 inventorsTop 20%
🗺 Massachusetts: #14,132 of 88,656 inventorsTop 20%
Overall (All Time): #535,638 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12359201 17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof Gregory Hinkle, Frederic Tremblay, Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li +6 more 2025-07-15
12286677 Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation Jesper Gromada, Xiping Cheng, Frederick Dewey, Tanya Teslovich Dostal, Claudia Schurmann +2 more 2025-04-29
11845963 HSD17B13 variants and uses thereof Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng, Jesper Gromada +3 more 2023-12-19
11753628 HSD17B13 variants and uses thereof Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng, Jesper Gromada +3 more 2023-09-12
11702700 Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation Jesper Gromada, Xiping Cheng, Frederick Dewey, Tanya Teslovich Dostal, Claudia Schurmann +2 more 2023-07-18
11485958 HSD17B13 variants and uses thereof Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng, Evangelos Pefanis +5 more 2022-11-01
11180757 17β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof Gregory Hinkle, Frederic Tremblay, Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li +6 more 2021-11-23
10961583 Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation Jesper Gromada, Xiping Cheng, Frederick Dewey, Tanya Teslovich Dostal, Claudia Schurmann +2 more 2021-03-30
10787647 HSD17B13 variants and uses thereof Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng, Evangelos Pefanis +5 more 2020-09-29